Company Overview

Abate AS Industries Limited (formerly Trijal Industries Limited) will hold its 35th Annual General Meeting on September 16, 2026, to approve the company's financial statements and several director appointments. The meeting will be conducted through video conferencing with remote e-voting available from September 13-15, 2026.

Financial Performance

Consolidated Results (₹ in lakhs):

  • Revenue from Operations: ₹1,594.09 (FY25: ₹140.87)
  • Profit Before Tax: ₹127.04 (FY25: ₹10.94)
  • Profit After Tax: ₹122.97 (FY25: ₹11.01)
  • Total Comprehensive Income: ₹123.00 (FY25: ₹11.01)

Standalone Results (₹ in lakhs):

  • Other Income: ₹211.55 (Previous year: ₹97.04)
  • Expenses: ₹56.82 (Previous year: ₹42.17)
  • Profit Before Tax: ₹154.73 (Previous year: ₹54.33)
  • Profit After Tax: ₹154.33 (Previous year: ₹54.33)

The significant improvement in financial performance reflects the company's strategic expansion through subsidiary acquisitions.

Corporate Actions & Capital Structure

The company executed several capital restructuring actions:

  • Bonus Issue: 1:1 bonus issue allotting 7,88,03,228 equity shares on August 1, 2025, increasing paid-up capital from ₹78.80 crore to ₹157.60 crore
  • Capital Increases: Authorized share capital increased from ₹95 crore to ₹158 crore (July 2025) and further to ₹200 crore (November 2025)
  • Preferential Allotment: Issued 73,787,128 shares at ₹22.28 per share via share swap for subsidiary acquisitions

Subsidiary Acquisitions

On February 25, 2025, the company acquired through share swap:

  • Salamath Import & Exports Private Limited (77.67% holding)
  • Prudential Management Services Private Limited (50.75% holding)
  • Sky International Trading WLL, Bahrain (70% holding)
  • SAIA Educational Support Services WLL, Bahrain (45% holding - Associate)

Subsidiary Performance (₹ in lakhs):

  • Sky International Trading: Revenue ₹12,345.04, Profit ₹751.04
  • Prudential Management: Revenue ₹3,094.99, Profit ₹209.76
  • Salamath Import & Exports: Revenue ₹603.82, Loss ₹23.47

Governance & Director Appointments

The Board composition includes 16 Directors with several appointments during FY 2025-26. Key agenda items for the AGM include re-appointment of Dr. Muhemmed Swadique as Executive Director and Julie G Varghese as Independent Director for second terms.

Regulatory Compliance & Auditors

The company paid SOP fines to BSE for delayed submission of financial results. Both Secretarial Audit Report by M/s. Lakshmmi Subramanian & Associates and Statutory Audit Report by M/s. Mahesh C Solanki & Co. contain no qualifications.

Future Expansion Plans

The company plans expansion to 44 international eye hospitals globally, a new super-specialty eye hospital in Manjeri, Kerala, and establishment of a private university focused on healthcare, business, and innovation through franchise agreements.

Accounting Policies & Segment Reporting

The financial statements are prepared in accordance with Indian Accounting Standards (Ind AS). The company changed depreciation method for subsidiaries from WDV to SLM in FY26, resulting in increased PPE carrying amount and reduced depreciation expense. The business is reported as a single healthcare segment.